Effexor and Leukine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Effexor (venlafaxine hydrochloride) and Leukine (sargramostim). Common drug interactions include pain among females and gastrooesophageal reflux disease among males.
The phase IV clinical study analyzes what interactions people have when they take Effexor and Leukine. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.
What is Effexor?
Effexor has active ingredients of venlafaxine hydrochloride. It is often used in depression. eHealthMe is studying from 99,493 Effexor users. Check the latest studies of Effexor.
What is Leukine?
Leukine has active ingredients of sargramostim. eHealthMe is studying from 2,188 Leukine users. Check the latest studies of Leukine.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
38 people who take Effexor and Leukine together, and have interactions are studied.

What are the common drug interactions of Effexor and Leukine, by gender? *:
female:
- Pain
- Neoplasm malignant (cancer tumour)
- Renal failure (kidney dysfunction)
- Abdominal pain
- Pyrexia (fever)
- Dizziness
- Hypertension (high blood pressure)
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Back pain
- Constipation
male:
- Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
- Metastases to bone (cancer spreads to bone)
- General physical health deterioration (weak health status)
- Hypoaesthesia (reduced sense of touch or sensation)
- Osteoarthritis (a joint disease caused by cartilage loss in a joint)
- Blood oestrogen increased
- Decreased interest
- Emotional distress
- Gait disturbance
- Gingival disorder (gum disease)
What are the common drug interactions of Effexor and Leukine, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Abdominal discomfort
- Colitis (inflammation of colon)
- Diarrhoea
- Injection site reaction
- Nausea (feeling of having an urge to vomit)
- Urinary tract infection
40-49:
- Neutropenia (an abnormally low number of neutrophils)
- Lethargy (tiredness)
- Vomiting
- Hypotension (abnormally low blood pressure)
- Blood sodium decreased
- Cerebral haemorrhage (bleeding within the brain)
- Decreased appetite
- Epistaxis (bleed from the nose)
- Eye pain
- Haemoglobin decreased
50-59:
- Back pain
- Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
- Dizziness
- Dysphagia (a condition in which swallowing is difficult or painful)
- Dysthymic disorder (mild chronic depression disorder)
- Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
- Epistaxis (bleed from the nose)
- Fall
- Hyperglycaemia (high blood sugar)
- Hypertension (high blood pressure)
60+:
- Cough
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Asphyxia (a condition in which there is an extreme decrease in the concentration of oxygen in the body)
- Asthenia (weakness)
- Atelectasis (partial or complete collapse of the lung)
- Atrophic vulvovaginitis (inflammation of the vulva)
- Breath sounds
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Cardiac arrest
- Cardiac failure congestive
What are the existing conditions these people have? *
- Lung Cancer - Non-Small Cell (lung cancer): 12 people, 31.58%
- Hypercalcaemia Of Malignancy (elevated calcium (ca+) level in the blood with cancer): 12 people, 31.58%
- Pain: 10 people, 26.32%
- Metastases To Bone (cancer spreads to bone): 9 people, 23.68%
- Malignant Melanoma (skin cancer rises from melancytes): 6 people, 15.79%
- Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 5 people, 13.16%
- Prostate Cancer: 4 people, 10.53%
- Nausea (feeling of having an urge to vomit): 4 people, 10.53%
- Breast Cancer Female: 2 people, 5.26%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 5.26%
* Approximation only. Some reports may have incomplete information.
Do you take Effexor and Leukine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Effexor and Leukine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Effexor:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Leukine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Effexor and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Leukine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on venlafaxine hydrochloride and sargramostim (the active ingredients of Effexor and Leukine, respectively), and Effexor and Leukine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Aspirin cause Staphylococcal Sepsis? - a second ago
- Breast Cancer and Breast Cancer Recurrent - 15 seconds ago
- Could Qinlock cause Tenderness? - 15 seconds ago
- Meloxicam and Fainting for Women aged 40-49 - 17 seconds ago
- Meloxicam and Vasovagal for Women aged 40-49 - 17 seconds ago
- Meloxicam and Syncope for Women aged 40-49 - 18 seconds ago
- Meloxicam and Passed Out for Women aged 40-49 - 18 seconds ago
- Meloxicam and Lightheadedness - Fainting for Women aged 40-49 - 18 seconds ago
- Drug interactions of Mavik and Asa - 20 seconds ago
- Could Zantac cause Breast Cancer Female? - 21 seconds ago